Colorectal cancer screening is getting another option for adults who may avoid stool tests or colonoscopy. Abbott has commercially launched SimpleScreen CRC in the United States, an FDA-approved blood test for colorectal cancer (CRC) screening in average-risk adults ages 45 and older. Freenome developed and...